You are here: Home » 
  1. News

| REBOOT PARADOX gets off to a start

Having received a positive vote from the ethics committee is great because it means that we can get started with the study straight away.

The detailed planning work that has taken place in recent months has been worthwhile. IHF GmbH developed the study design together with Professor Dr Julinda Mehilli, Director and Initiator of REBOOT PARADOX. The ethics committee was happy with the study and approved it without conditions.

The REBOOT PARADOX study investigates treatment approaches for patients with paradoxical aortic valve stenosis. It compares quality of life and mortality rates of patient groups with replacement aortic valves who also received drug treatment and patient groups receiving only drug treatment.

News

We would like to get to know you and your ideas.

Start project

Consent to the use of cookies

In order to make our website more appealing to visitors and to enable the use of certain functions, we use cookies on various pages. By continuing to use the website, you consent to the use of cookies. Find out more.

I agree